These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12116277)

  • 21. Three novel mutations in the RET proto-oncogene.
    Kalinin VN; Amosenko FA; Shabanov MA; Lubchenko LN; Hosch SB; Garkavtseva RF; Izbicki JR
    J Mol Med (Berl); 2001 Oct; 79(10):609-12. PubMed ID: 11692159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.
    Orlandi F; Chiefari E; Caraci P; Mussa A; Gonzatto I; De Giuli P; Giuffrida D; Angeli A; Filetti S
    J Endocrinol Invest; 2001 Jan; 24(1):51-5. PubMed ID: 11227733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
    Jimenez C; Habra MA; Huang SC; El-Naggar A; Shapiro SE; Evans DB; Cote G; Gagel RF
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4142-5. PubMed ID: 15292360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
    Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
    JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.
    Wiench M; Wygoda Z; Gubala E; Wloch J; Lisowska K; Krassowski J; Scieglinska D; Fiszer-Kierzkowska A; Lange D; Kula D; Zeman M; Roskosz J; Kukulska A; Krawczyk Z; Jarzab B
    J Clin Oncol; 2001 Mar; 19(5):1374-80. PubMed ID: 11230481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of metastatic medullary thyroid carcinoma: early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens.
    Russo D; Arturi F; Chiefari E; Meringolo D; Bianchi D; Bellanova B; Filetti S
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3378-82. PubMed ID: 9329372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RET activation in medullary carcinomas.
    Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
    Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
    [No Abstract]   [Full Text] [Related]  

  • 28. [Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].
    Musholt PB; Musholt TJ; Moley JF; Scheumann GF
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):261-5. PubMed ID: 14518256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Bugalho MJ; Coelho I; Sobrinho LG
    Eur J Endocrinol; 2000 Jun; 142(6):573-5. PubMed ID: 10822219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ret-proto-oncogene analysis in medullary thyroid carcinoma.
    O'Keeffe DA; Hill AD; Sheahan K; Ryan F; Barton D; Fitzgerald RJ; McDermott EW; O'Higgins NJ
    Ir J Med Sci; 1998; 167(4):226-30. PubMed ID: 9868860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions].
    Kalinin VN; Amosenko FA; Puskas C; Frilling A; Broelsch CE
    Genetika; 1998 Aug; 34(8):1157-9. PubMed ID: 9777362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
    Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
    Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endocrine surgery. Series 6: Alteration of RET proto-oncogene and clinical implication in medullary thyroid carcinoma. Genetic screening of family members at risk for inherited medullary thyroid carcinoma].
    Kitamura Y; Shimizu K; Tanaka S
    Nihon Ika Daigaku Zasshi; 1996 Jun; 63(3):228-32. PubMed ID: 8707923
    [No Abstract]   [Full Text] [Related]  

  • 34. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations.
    Chang TC; Wu SL; Hsiao YL
    Acta Cytol; 2005; 49(5):477-82. PubMed ID: 16334022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys-->Arg).
    Nakao A; Naomoto Y; Kataoka M; Haisa M; Kataoka K; Saitoh S; Fujiwara T; Yamatsuji T; Shigemitsu K; Umeoka T; Isozaki H; Futami H; Yamaguchi K; Tanaka N
    Jpn J Clin Oncol; 2001 Apr; 31(4):157-61. PubMed ID: 11386462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.
    Lombardo F; Baudin E; Chiefari E; Arturi F; Bardet S; Caillou B; Conte C; Dallapiccola B; Giuffrida D; Bidart JM; Schlumberger M; Filetti S
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1674-80. PubMed ID: 11932300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.
    Eng C; Mulligan LM; Healey CS; Houghton C; Frilling A; Raue F; Thomas GA; Ponder BA
    Cancer Res; 1996 May; 56(9):2167-70. PubMed ID: 8616867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
    Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
    Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.